Notably, PRKAA2 expression is significantly elevated in hepatoblastoma (HB), where it acts as an oncogenic factor by promoting cell proliferation and inhibiting ferroptosis (27). This evidence concerns the gene PRKAA2 and hemoglobin measurement.